Literature DB >> 3425738

Intracellular calcium levels in phorbol ester-induced contractions of vascular muscle.

M J Jiang1, K G Morgan.   

Abstract

Intracellular calcium concentration ([Ca2+]i) was measured with aequorin in ferret and rat aortic strips contracted with phorbol esters. In ferret aorta, 12-deoxyphorbol 13-isobutyrate 20-acetate (DPBA, 1 microM) induced contractions without significantly increasing [Ca2+]i, whereas 21 mM K+ induced smaller contractions with a significant rise in [Ca2+]i. Ca2+-free 2.5 mM ethyleneglycol-bis(beta-aminoethylether)-N,N'-tetraacetic acid (EGTA)-physiological saline solution (PSS) had no effect on DPBA-induced tension, whereas it abolished contractions induced by 66 mM K+. The alpha 1-adrenergic agonist phenylephrine (10(-5) M) induced less than 10% of the tension with no initial [Ca2+]i spike under Ca-free conditions. In rat aorta, both phorbol 12-myristate 13-acetate (PMA, 2 microM) and DPBA (1 microM) induced contractions without increasing [Ca2+]i; Ca2+-free EGTA-PSS or the addition of the calcium channel blocker gallopamil (D600, 1 microM), however, abolished greater than 50% of the tension induced by either phorbol ester with a decrease in [Ca2+]i. These results are consistent with the idea that 1) resting [Ca2+]i is both sufficient and required to support phorbol ester-induced contractions in two vascular smooth muscles, suggesting an increased sensitivity of the contractile apparatus for Ca2+, and 2) there are differences in the mechanisms by which phorbol esters and alpha 1-agonists may activate vascular smooth muscle.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3425738     DOI: 10.1152/ajpheart.1987.253.6.H1365

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  45 in total

1.  Preferential role of intracellular Ca2+ stores in regulation of isometric force in NIH 3T3 fibroblast fibres.

Authors:  K Nobe; H Nobe; K Obara; R J Paul
Journal:  J Physiol       Date:  2000-12-15       Impact factor: 5.182

2.  The frequency response of smooth muscle stiffness during Ca2+-activated contraction.

Authors:  G H Shue; F V Brozovich
Journal:  Biophys J       Date:  1999-05       Impact factor: 4.033

Review 3.  The role of calcium in the control of vascular tone as assessed by the Ca2+ indicator aequorin.

Authors:  K G Morgan
Journal:  Cardiovasc Drugs Ther       Date:  1990-10       Impact factor: 3.727

4.  Sympathetic neural inhibition of conducted vasodilatation along hamster feed arteries: complementary effects of alpha1- and alpha2-adrenoreceptor activation.

Authors:  Sara J Haug; Steven S Segal
Journal:  J Physiol       Date:  2004-12-02       Impact factor: 5.182

5.  Modulation of the [Ca2+] sensitivity of myosin phosphorylation in intact swine arterial smooth muscle.

Authors:  C M Rembold
Journal:  J Physiol       Date:  1990-10       Impact factor: 5.182

6.  Mechanisms of intrinsic tone in ferret vascular smooth muscle.

Authors:  J Pawlowski; K G Morgan
Journal:  J Physiol       Date:  1992-03       Impact factor: 5.182

7.  Study of the mechanisms involved in the vasorelaxation induced by (-)-epigallocatechin-3-gallate in rat aorta.

Authors:  Ezequiel Alvarez; Manuel Campos-Toimil; Hélène Justiniano-Basaran; Claire Lugnier; Francisco Orallo
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

8.  Contraction of vascular smooth muscle induced by phorbol 12,13 dibutyrate in human and rat pulmonary arteries.

Authors:  J P Savineau; R Marthan; H Crevel
Journal:  Br J Pharmacol       Date:  1991-11       Impact factor: 8.739

9.  Phorbol 12,13-dibutyrate increases vascular tone but has a dual action on intracellular calcium levels in porcine coronary arteries.

Authors:  T Mori; T Yanagisawa; N Taira
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-03       Impact factor: 3.000

Review 10.  Regulation of the smooth muscle contractile phenotype by nonmuscle myosin.

Authors:  Ozgur Ogut; Samantha L Yuen; Frank V Brozovich
Journal:  J Muscle Res Cell Motil       Date:  2008-03-18       Impact factor: 2.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.